This is a study to evaluate the level of pain control and safety of different doses of a new extended-release pain med (CG5503) in people with moderate-to-severe chronic lower back pain. The new med will be compared to both oxycodone CR and a placebo. This international study is currently recruiting patients.
Read morePregnancy can result in back pain, which can linger for a time after the delivery. Three possible causes for the back pain might... Read more »
One of the major risks of having spine surgery is the development of an infection. Discitis is an uncommon infection of the spinal disc... Read more »
Medications are the most frequently recommended treatment for low back pain. Research has shown that 80% of primary care patients with... Read more »
Many would argue that back pain is inevitable and for some it becomes a sudden reality. Bending over to pick up a piece of paper, moving... Read more »
Spondylolisthesis (spaun-di-lo-lie-thee-sis) is a mouthful and is a common cause of low back pain (although it can exist anywhere in the... Read more »
Australian researchers say even very severe back pain is unlikely to mean the sufferer has a more serious health issue such as a broken vertebrae or... Read more »
This is a study to determine the safety and effectiveness of extended-release Vicodin (hydrocodone and acetaminophen) in patients with moderate to... Read more »
This is a study to determine the safety and effectiveness of a new transdermal pain med in patients with chronic lower back pain. This national study... Read more »
According to a new study, practicing yoga may help decrease lower back pain. Read more »